CEPRES Fund Screening

Evaluate more funds with less time and greater confidence

Talk to sales

Empower your team to drive investment alpha

CEPRES Fund Screening helps you manage your forward calendar and get all the track record analytics you need for GPs. Drill down through GP track records from funds to deals to portfolio companies with risk and return analyses at every level. Perform sensitivity analysis on GPs’ deals and see if success is repeatable or if they caught lightning in a bottle. Audit their segment exposure to make better informed, data-driven investments.

Get started

Look through to drivers of risk and returns

Confirm returns in GP pitch books with CEPRES’s out-of-the-box dashboards and analytics — all backed by portfolio company operating cash flows. Explore if a GP’s performance is repeatable or propped up by the success of one deal.

Move beyond spreadsheets

Instantly get detailed fund, deal and operating company analyses with single click analytics. From IRR and TVPI to EBITDA multiples and value creation, CEPRES provides the private equity data you need to make better investment decisions.

Manage forward calendar

CEPRES Fund Screening significantly increases the GP track records you can analyze, empowering you to commit your capital to the right partners for your investment thesis.


Typically, CEPRES clients cut their fund screening time by 90%, allowing them to redeploy time more effectively.


CEPRES Fund Screening often enables LPs to review four times as many track records within the same time horizon


CEPRES works directly with your GPs to source the data you need to meet your portfolio goals. We verify every data point, down to individual operating cash flows, ensuring that 100% of your data is accurate, actionable and governed.

Generate instant analytics to power better investment decisions

Amidst volatility, choosing new private illiquid funds with 10+ year lockups can feel risky. Many investors use customized CRMs to track their pipeline and Excel for track record analysis, creating data challenges and consuming an outsized percentage of your time. With CEPRES Fund Screening, you can spend your time making capital decisions instead of building complex macros or tracking dozens of spreadsheets at a time.

CEPRES's data advantage

Track record analysis used to involve painstakingly manual processes, navigating spreadsheets and tapping your network for additional insight. CEPRES Fund Screening enables you to automate these processes and get instant answers to your most important questions. Drive transparency, efficiency and accuracy in your fund screening, allowing you to evaluate more opportunities and maximize impact.

Accelerate your digital transformation

$Thanks to CEPRES, we could triple our US lower-mid market buyout allocation by expanding our due diligence efforts massively. All with a PE team of three.

Investment Manager Pension Plan


Helping a large insurer slash due diligence time by 25%

An insurer spent significant time engaged in GP screening and track record due diligence. CEPRES provided the LP with a detailed fund, deal and operating company analysis and the ability to benchmark against 100k+ deals. The insurer immediately realized 25%-time savings by replacing manual analysis with an automated, systematic one. It also gained a complete audit trail for all investment decisions to present to the investment committee.

Thought Leadership


CEPRES 2021 Product Highlights

CEPRES has worked tirelessly to deliver value to our customers. CEPRES has added major capabilities to power your private equity digital transformation. Simply, the most powerful platform in private equity got smarter.


Private Equity Technology Investments Outperform Traditional Sectors

Technology investing in private equity, already a hot sector before covid, gained further momentum during 2020. The data shows further increases in capital flowing to tech investment deals and away from traditional sectors, combined with increased returns and thriving fundamentals.


Five Ways Deal Performance Data Can Power Up Private Equity Investment Program

By the middle of 2021, private equity buyout deals had already matched the full-year totals for 2019 and 2020. For the first time, buyout deal value is on track to top $1T. The pressure on GPs has never been more intense.

View all

Ready to start driving better investment outcomes?